{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:38:37Z","timestamp":1792618717492,"version":"4.5.0"},"reference-count":26,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    This study aimed to evaluate the prevalence of anti\u2010HBc seropositivity and examine the longitudinal changes in anti\u2010HBc IgG S\/CO reactivity, with particular focus on seroreversion (loss of anti\u2010HBc antibodies) in immunocompromised patients by correlating laboratory data with clinical history. In this retrospective study (January 2017 and June 2024), serum samples from a tertiary care hospital were tested for hepatitis B serological markers, using chemiluminescent microparticle immunoassay (CMIA). Patients with \u2265\u20093 anti\u2010HBc IgG measurements were evaluated for longitudinal monitoring of antibody dynamics. Medical records were reviewed for chronic HBV infection, co\u2010morbidities, and anti\u2010HBc loss in immunosuppressed patients. A total of 35,017 clinical samples from 27,758 participants were analysed. In this hospital\u2010based cohort, the anti\u2010HBc IgG seropositivity rate was 32.0%. Seropositive individuals were older than seronegatives (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Longitudinal analyses was performed on 1397 patients with \u2265\u20093 IgG measurements; consistently 434 remained reactive and 963 remained negative. Linear mixed\u2010effects analysis showed a significant decline over time (F\n                    <jats:sub>(1,1679)<\/jats:sub>\n                    \u2009=\u200933.65;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Among immunosuppressed patients, 94 initially reactive cases were evaluated; permanent loss occurred in 80.9%. Seroreversion rates were 66.7% in rheumatology, 85.2% in hematology, 100% in oncology, and 69.2% in other departments; massive immunosuppressive cohort (hematology\/oncology) had a higher likelihood of seroreversion in an unadjusted, exploratory comparison (OR 3.27;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.04). This study demonstrates time\u2010dependent decline in anti\u2010HBc IgG S\/CO reactivity. Seroreversion is common in immunocompromised patients. As anti\u2010HBc reflects past exposure rather than active infection, its loss or negativity in immunosuppressed patients\u2014including seronegative occult HBV infection\u2014means serology alone may give false reassurance. Combined HBsAg\/anti\u2010HBc serology with HBV DNA testing is therefore recommended to detect occult infection and assess reactivation risk in this high\u2010risk group.\n                  <\/jats:p>","DOI":"10.1002\/jmv.71139","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:43:36Z","timestamp":1788777816000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in Anti\u2010HBc Positivity and Antibody Loss in Immunocompromised Patients: An Eight\u2010Year Hospital\u2010Based Analysis From a Tertiary Center in Turkey"],"prefix":"10.1002","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9145-083X","authenticated-orcid":false,"given":"Hasan","family":"Zeybek","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology Gulhane Training and Research Hospital Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0150-4417","authenticated-orcid":false,"given":"Tu\u011frul","family":"Ho\u015fbul","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology Health Sciences University Gulhane Faculty of Medicine Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2303-8234","authenticated-orcid":false,"given":"Ramazan","family":"G\u00fcmral","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology Health Sciences University Gulhane Faculty of Medicine Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9651-3502","authenticated-orcid":false,"given":"Fatih","family":"\u015eahiner","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology Health Sciences University Gulhane Faculty of Medicine Ankara T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"World Health Organization. Global Hepatitis Report 2024: Action for Access in Low and Middle\u2010income Countries. Published on 9 April 2024. Website:https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.024"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-020-00522-0"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21850-9"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00549-4"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyae105"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.013"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.02.009"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.038"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc3961"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.05.005"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/v11111049"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1832731"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.03.018"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020137"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-142393"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15536"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-06845-2"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000322"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-337"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S357819"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-18136-2"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.034"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.03.014"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.10.006"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.10.006"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.71139","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jmv.71139","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.71139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:57:18Z","timestamp":1792616238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.71139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/jmv.71139"],"URL":"https:\/\/doi.org\/10.1002\/jmv.71139","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71139"}}